Suppr超能文献

预防和治疗中心静脉置管过程中的扩张器损伤。

Prevention and treatment of dilator injuries during central venous catheter placement.

机构信息

Greater Pittsburgh Surgical Alliance, Sewickley, Pa.

出版信息

J Vasc Surg Venous Lymphat Disord. 2019 Nov;7(6):789-792. doi: 10.1016/j.jvsv.2019.06.020. Epub 2019 Aug 27.

Abstract

BACKROUND

Misuse of vascular dilators during the placement of central venous catheters has been infrequently reported and can lead to devastating intrathoracic hemorrhage and death. These injuries should be preventable in most cases. If a major intrathoracic vascular injury is recognized intraoperatively, less invasive treatment options are available to minimize the consequences.

METHODS

The records of 20 patients who suffered 21 major vascular injuries during insertion of central venous catheters, ports, or dialysis catheters and resulted in malpractice claims over the course of 8 years were analyzed to determine the mechanism of injury, the timing of diagnosis, and how these injuries were treated. How the injury could have been prevented, why earlier diagnosis was not made, and what treatment options were possible were also examined.

RESULTS

Twelve women and eight men were documented to have sustained intrathoracic major venous injuries during catheter insertions. There were five injuries to the superior vena cava, six to the right innominate vein, and 10 to the left innominate vein. All procedures were done using fluoroscopic guidance, and resistance to passage of the dilators was documented in eight cases. In most cases, the operator reported inserting the dilators to their maximum length. In four cases, the catheter could be seen intraoperatively in the thoracic cavity. Bleeding was diagnosed in the operating room in 11 cases, in the postanesthesia care unit in seven cases, and on postoperative days 2 and 5 after misplaced catheters were removed. Ten patients underwent thoracotomies and one patient each underwent thoracoscopy and placement of a covered stent in an attempt to stop the hemorrhage. Eight patients died before the diagnosis was made. Seventeen patients died.

CONCLUSIONS

In spite of U.S. Food and Drug Administration warnings, dilators are still inserted too far in patients, resulting in devastating hemorrhage. These complications are preventable if proper technique is used. When a catheter is noted to be misplaced, it must not be removed before either a covered stent or thoracoscopy is available; otherwise, uncontrolled hemorrhage into the chest may occur. If a patient becomes unstable in the operating room or immediate postoperative period injury to a major vein must be considered and corrected quickly.

摘要

背景

中心静脉导管置管过程中血管扩张器的误用虽鲜有报道,但可导致灾难性的胸腔内出血和死亡。在大多数情况下,这些损伤是可以预防的。如果术中发现主要的胸腔内血管损伤,可采用创伤较小的治疗方法来最小化后果。

方法

对 8 年间因中心静脉导管、端口或透析导管置入导致 21 例重大血管损伤并引发医疗事故索赔的 20 例患者的记录进行分析,以确定损伤机制、诊断时机以及这些损伤的治疗方法。还检查了损伤是如何发生的、为何未能更早诊断以及可能的治疗方案。

结果

共记录了 12 名女性和 8 名男性在导管插入过程中发生胸腔内大静脉损伤。5 例损伤位于上腔静脉,6 例位于右无名静脉,10 例位于左无名静脉。所有手术均采用透视引导进行,8 例记录到扩张器插入时有阻力。在大多数情况下,操作者报告扩张器已插入最大长度。4 例术中可见导管位于胸腔内。11 例在手术室诊断出血,7 例在麻醉后护理单元诊断出血,5 例在放置错位导管后第 2 和第 5 天诊断出血。10 例患者接受了开胸手术,1 例患者接受了胸腔镜检查和带膜支架置入以试图止血。8 例患者在诊断前死亡。17 例患者死亡。

结论

尽管美国食品和药物管理局发出警告,但扩张器仍被插入患者体内过深,导致严重出血。如果采用正确的技术,这些并发症是可以预防的。当导管被发现错位时,在带膜支架或胸腔镜可用之前,不得将其移除;否则,可能会发生不受控制的胸腔内出血。如果患者在手术室或术后即刻期间不稳定,必须考虑并迅速纠正大静脉损伤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验